Hospital Univ Vall dHebron

Barcelona 08035

0 studies enrolling now · 1 studies all time

What they study most

Gastric Cancer Third Line, Unresectable, Recurrent, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Studies at this site

• Avelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300) — Completed